Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
ViroMissile, Inc.
Canadian Cancer Trials Group
St. Jude Children's Research Hospital
MacroGenics
City of Hope Medical Center
HiFiBiO Therapeutics
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Novelty Nobility, Inc.
Kazia Therapeutics Limited
NextPoint Therapeutics, Inc.
Xencor, Inc.
Pfizer
DNAtrix, Inc.
National Cancer Institute (NCI)
Corvus Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
SCRI Development Innovations, LLC
Tempest Therapeutics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
MacroGenics
Emory University
Celgene
Emory University
Virginia Commonwealth University
Daiichi Sankyo
Merck Sharp & Dohme LLC
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center